The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: -1.00 (-2.38%)
Spread: 2.00 (5.00%)
Open: 42.00
High: 42.00
Low: 41.00
Prev. Close: 42.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Gov Future Fund invests £250,000 in Pulsiv

10 Aug 2020 07:00

RNS Number : 5323V
Frontier IP Group plc
10 August 2020
 

RNS Reach

AIM: FIPP

10 August 2020

 

Frontier IP Group plc

("Frontier IP" or the "Group")

 

 

Portfolio news - UK Government Future Fund invests £250,000 in Pulsiv Solar as part of £500,000 fund raising

 

Frontier IP, a specialist in commercialising intellectual property, today notes the following announcement from portfolio company Pulsiv Solar Limited ("Pulsiv" or the "Company") that it has raised £500,000 via a convertible loan, including a £250,000 investment from the UK Government's Future Fund.

 

The investment from the Future Fund, which was established to support innovative businesses through the COVID-19 outbreak, has been matched by the Group and the University of Plymouth Enterprise Limited, the University of Plymouth's commercial consultancy and contract research arm. They have invested £50,000 and £200,000 respectively. Frontier IP holds an 18.9 per cent equity stake in the Company.

 

The convertible loan forms part of broader plans for funding Pulsiv, a University of Plymouth spin out. The Company recently announced it was in discussions with investors to raise money which, if completed, would be at a significant premium to the current book value at which it is held by the Group. Discussions continue and it is anticipated that any further funding will be in the form of equity. The convertible loan announced today will not affect the Group's book value of Pulsiv.

 

Frontier IP chief executive officer Neil Crabb said: "The Future Fund was established to support the UK's most innovative businesses through the coronavirus outbreak. Following the significant commercial and technical progress recently made by Pulsiv, the Government's support means we are in an even stronger position to realise the full range of opportunities open to the Company's technology."

 

Pulsiv Solar statement begins:

 

 

UK Government Future Fund invests £250,000 in Pulsiv Solar as part of £500,000 fund raising

 

 

10 August 2020 Pulsiv Solar ("Pulsiv" or the "Company") today announces that it has successfully raised £500,000 via a convertible loan including £250,000 investment from the UK Government's Future Fund, established to support innovative businesses through the COVID-19 outbreak.

 

The Future Fund's investment has been matched by University of Plymouth Enterprise Limited, the commercial consultancy and contract arm of the University of Plymouth, and Frontier IP Group plc ("Frontier IP" or the "Group"), a specialist in commercialising intellectual property and a founding shareholder in Pulsiv. They have invested £200,000 and £50,000 respectively.

 

The convertible loan forms part of broader plans for funding Pulsiv, a University of Plymouth spin out. The Company recently announced it was in discussions with investors to raise money and it is anticipated that any further funding will be in the form of equity.

 

The funding will allow Pulsiv to step up development of its novel technology to improve the energy efficiency of power conversion for use in a wide range of industrial applications.

 

Pulsiv has already announced that it has:

 

· Started design work funded by a major multinational to incorporate the technology into a new product line

· Engaged in discussions with a number of other large multinational companies about a wide range of further industrial applications

· Filed a further two priority patent applications on top of the one filed late last year. The Company now has eight separate patent families, five of which have progressed to grant, across all major territories worldwide, reflecting the significant amount of development undertaken and the strength of the intellectual property position underpinning it.

 

The step change in industrial engagement follows the Company successfully developing a series of demonstration products which show the technology not only improves energy efficiency but has the potential to reduce costs.

 

Robert Bosch Limited, part of Bosch, has been working with Pulsiv to optimise the design of the Company's energy-efficient solar microinverter prototype. When the prototype moves into full-scale commercial production, it will allow Pulsiv to market microinverters as "Engineered by Bosch".

 

 

Adrian Dawson, Director of University of Plymouth Enterprise Limited (UoPEL), said: "Pulsiv is part of an exciting suite of spinout companies transforming the world-leading research undertaken at the University of Plymouth into commercially available products that can have real-world benefits. This latest success is a further demonstration that governments and industry are recognising its potential, and UoPEL is delighted to support its continued growth."

 

Fay Davies, Business Development Manager at Plymouth Science Park, said: "We are delighted that Future Fund investment has been made to support the ground-breaking work of Pulsiv Solar Limited. Sustainability is a key driver of the South West's tech sector and we look forward to supporting the commercialisation of this innovative and important technology."

 

Pulsiv Solar technical director Dr Zaki Ahmed said: "This funding will be invaluable in supporting our work to commercialise our technology. Alongside the recent steps forward we have taken in commercialising the technology, it gives us grounds to be very optimistic about the future prospects for the Company"

 

 

 

Pulsiv Solar statement ends

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / James Hornigold

 

 

 

 

 

 

 

 

 

ABout frontier IP

The Group's convertible loan to Pulsiv was made by Frontier IP Management Limited, a wholly-owned subsidiary and an Appointed Representative of Privium Fund Management (UK) Limited ("Privium") which is authorised and regulated by the Financial Conduct Authority ("FCA") in the United Kingdom.

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKKOBNDBKDBFK
Date   Source Headline
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.